Cannabidiol: Anxiety Relief or Fool’s Gold?

Authors

Jase Bakker

Files

Document Type

Poster

Description

This literature review evaluates the efficacy of cannabidiol (CBD) as a treatment for anxiety in adults and adolescents. A systematic search of three databases (PubMed, PsychInfo, EMBASE) yielded 775 articles, with 11 randomized controlled trials meeting inclusion criteria. These studies utilized diverse methodologies, including public speaking tests, neuroimaging, and physiological measures, to assess CBD's effects compared to placebo. • Findings indicate mixed results: moderate doses (300 mg) show promise in social anxiety, while other trials report inconsistent outcomes due to dosing and bioavailability challenges. Limitations such as small sample sizes and variable methodologies hinder definitive conclusions. Further research is needed to optimize dosing, explore long-term effects, and establish CBD's role as a therapeutic option for anxiety disorders.

Department

Physician Assistant Studies

Degree Name

Master of Physician Assistant Studies (MPAS)

Date of Work

2025

Publication Date

Spring 5-2025

Disciplines

Medicine and Health Sciences

Recommended Citation

Bakker, Jase, "Cannabidiol: Anxiety Relief or Fool’s Gold?" (2025). Physician Assistant Scholarly Project Posters. 315.
https://commons.und.edu/pas-grad-posters/315